Open AccessLong-Term Mortality and Bone Safety in Patients with End-Stage Renal Disease Receiving Lanthanum Carbonate
Author(s) -
Alastair J. Hutchison,
Andrew Whelton,
Ravi Thadhani,
Heinrich Achenbach,
Andrea Vergani,
Jingyang Wu,
Gillian Hall
Publication year - 2018
Publication title -
the nephron journals/nephron journals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.951
H-Index - 72
eISSN - 2235-3186
pISSN - 1660-8151
DOI - 10.1159/000492603
Subject(s) - medicine , lanthanum carbonate , end stage renal disease , kidney disease , nephrology , disease , stage (stratigraphy) , intensive care medicine , term (time) , lanthanum , surgery , hyperphosphatemia , physics , paleontology , inorganic chemistry , chemistry , quantum mechanics , biology
This post-marketing observational study assessed the long-term safety of lanthanum carbonate (LaC) in US patients with end-stage renal disease (NCT00567723).